What is the P/E ratio of XRF Scientific 2024?
The XRF Scientific P/E ratio is 20.35.
Own the gold standard ✨ in financial data & analytics
Subscribe for $2 
Overview
Profile
XRF Scientific Stock stock price, forecast, news, chart, split, dividend and analysis XRF Scientific ariva, XRF Scientific onvista, XRF Scientific finanzen.net, XRF Scientific aktienfinder, XRF Scientific marketscreener, XRF Scientific marketwatch, XRF Scientific bloomberg, XRF Scientific handelsblatt, XRF Scientific wiwo, XRF Scientific forum
XRF.AX
AU000000XRF8
Price
Price
1.35 AUD
Today +/-
+0 AUD
Today %
+0 %
TickerXRF.AX
ISINAU000000XRF8
P
XRF Scientific Revenue, EBIT, Net Income AU000000XRF8 ·
3 years
5 years
10 years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into XRF Scientific, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by XRF Scientific from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects XRF Scientific’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of XRF Scientific. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into XRF Scientific’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing XRF Scientific’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on XRF Scientific’s growth potential.
XRF Scientific Revenue, EBIT and net profit per share
| Date | XRF Scientific Revenue | XRF Scientific EBIT | XRF Scientific Net Income |
|---|---|---|---|
| 2026e | 68.68 M AUD | 16.67 M AUD | 10.88 M AUD |
| 2025e | 64.44 M AUD | 15.66 M AUD | 10.18 M AUD |
| 2024e | 59.69 M AUD | 13.94 M AUD | 9.07 M AUD |
| 2023 | 55.26 M AUD | 11.97 M AUD | 7.69 M AUD |
| 2022 | 40.01 M AUD | 8.23 M AUD | 6.08 M AUD |
| 2021 | 31.29 M AUD | 5.96 M AUD | 5.13 M AUD |
| 2020 | 29.09 M AUD | 4.61 M AUD | 3.12 M AUD |
| 2019 | 29.03 M AUD | 3.36 M AUD | 2.14 M AUD |
| 2018 | 24.25 M AUD | 1.82 M AUD | 1.02 M AUD |
| 2017 | 21.54 M AUD | 1.2 M AUD | 793,850 AUD |
| 2016 | 21.13 M AUD | 2.52 M AUD | 1.54 M AUD |
| 2015 | 20.67 M AUD | 3.89 M AUD | 2.64 M AUD |
| 2014 | 21.85 M AUD | 3.97 M AUD | 2.44 M AUD |
| 2013 | 22.81 M AUD | 5.32 M AUD | 3.81 M AUD |
| 2012 | 25.72 M AUD | 5.17 M AUD | 3.58 M AUD |
| 2011 | 20.33 M AUD | 4.26 M AUD | 2.63 M AUD |
| 2010 | 12.48 M AUD | 720,000 AUD | 300,000 AUD |
| 2009 | 16.81 M AUD | 2.12 M AUD | 1.95 M AUD |
| 2008 | 14.71 M AUD | 1.38 M AUD | 920,000 AUD |
| 2007 | 12.58 M AUD | 850,000 AUD | 240,000 AUD |
| 2006 | 6.02 M AUD | 770,000 AUD | 630,000 AUD |
| 2005 | 3.03 M AUD | 290,000 AUD | 180,000 AUD |
| 2004 | 5.99 M AUD | 610,000 AUD | 620,000 AUD |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 5.99 M AUD | 610,000 AUD | 620,000 AUD |
| 2005 | 3.03 M AUD | 290,000 AUD | 180,000 AUD |
| 2006 | 6.02 M AUD | 770,000 AUD | 630,000 AUD |
| 2007 | 12.58 M AUD | 850,000 AUD | 240,000 AUD |
| 2008 | 14.71 M AUD | 1.38 M AUD | 920,000 AUD |
| 2009 | 16.81 M AUD | 2.12 M AUD | 1.95 M AUD |
| 2010 | 12.48 M AUD | 720,000 AUD | 300,000 AUD |
| 2011 | 20.33 M AUD | 4.26 M AUD | 2.63 M AUD |
| 2012 | 25.72 M AUD | 5.17 M AUD | 3.58 M AUD |
| 2013 | 22.81 M AUD | 5.32 M AUD | 3.81 M AUD |
| 2014 | 21.85 M AUD | 3.97 M AUD | 2.44 M AUD |
| 2015 | 20.67 M AUD | 3.89 M AUD | 2.64 M AUD |
| 2016 | 21.13 M AUD | 2.52 M AUD | 1.54 M AUD |
| 2017 | 21.54 M AUD | 1.2 M AUD | 793,850 AUD |
| 2018 | 24.25 M AUD | 1.82 M AUD | 1.02 M AUD |
| 2019 | 29.03 M AUD | 3.36 M AUD | 2.14 M AUD |
| 2020 | 29.09 M AUD | 4.61 M AUD | 3.12 M AUD |
| 2021 | 31.29 M AUD | 5.96 M AUD | 5.13 M AUD |
| 2022 | 40.01 M AUD | 8.23 M AUD | 6.08 M AUD |
| 2023 | 55.26 M AUD | 11.97 M AUD | 7.69 M AUD |
| 2024e | 59.69 M AUD | 13.94 M AUD | 9.07 M AUD |
| 2025e | 64.44 M AUD | 15.66 M AUD | 10.18 M AUD |
| 2026e | 68.68 M AUD | 16.67 M AUD | 10.88 M AUD |
XRF Scientific Stock Ratios
Simple
Expanded
Income Statement
Balance Sheet
Cashflow
| 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5 | 3 | 6 | 12 | 14 | 16 | 12 | 20 | 25 | 22 | 21 | 20 | 21 | 21 | 24 | 29 | 29 | 31 | 40 | 55 | 59 | 64 | 68 |
| - | -40.00 | 100.00 | 100.00 | 16.67 | 14.29 | -25.00 | 66.67 | 25.00 | -12.00 | -4.55 | -4.76 | 5.00 | - | 14.29 | 20.83 | - | 6.90 | 29.03 | 37.50 | 7.27 | 8.47 | 6.25 |
| 60.00 | 33.33 | 33.33 | 41.67 | 35.71 | 37.50 | 33.33 | 40.00 | 36.00 | 40.91 | 38.10 | 40.00 | 38.10 | 38.10 | 37.50 | 37.93 | 41.38 | 41.94 | 42.50 | 40.00 | - | - | - |
| 3 | 1 | 2 | 5 | 5 | 6 | 4 | 8 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 11 | 12 | 13 | 17 | 22 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 1 | 2 | 0 | 4 | 5 | 5 | 3 | 3 | 2 | 1 | 1 | 3 | 4 | 5 | 8 | 11 | 13 | 15 | 16 |
| - | - | - | - | 7.14 | 12.50 | - | 20.00 | 20.00 | 22.73 | 14.29 | 15.00 | 9.52 | 4.76 | 4.17 | 10.34 | 13.79 | 16.13 | 20.00 | 20.00 | 22.03 | 23.44 | 23.53 |
| 0 | 0 | 0 | 0 | 0 | 1 | 0 | 2 | 3 | 3 | 2 | 2 | 1 | 0 | 1 | 2 | 3 | 5 | 6 | 7 | 9 | 10 | 10 |
| - | - | - | - | - | - | - | - | 50.00 | - | -33.33 | - | -50.00 | - | - | 100.00 | 50.00 | 66.67 | 20.00 | 16.67 | 28.57 | 11.11 | - |
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 60.79 | 60.79 | 38.89 | 85.69 | 90.33 | 91.61 | 91.61 | 103.63 | 127.13 | 130.73 | 132.16 | 132.16 | 133.13 | 133.83 | 133.83 | 133.83 | 133.83 | 134.35 | 135.47 | 136.69 | 0 | 0 | 0 |
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Details
Keystats
ⓘRevenue and Growth
The XRF Scientific Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.
Gross Margin
The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.
EBIT and EBIT Margin
EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.
Income and Growth
Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.
Shares Outstanding
Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.
Interpreting Year to Year Comparison
Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.
Expectations and Predictions
Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the XRF Scientific is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.
XRF Scientific stock margins AU000000XRF8 ·
The XRF Scientific margin analysis displays the gross margin, EBIT margin, as well as the profit margin of XRF Scientific. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for XRF Scientific.
3 years
5 years
10 years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the XRF Scientific's sales revenue. A higher gross margin percentage indicates that the XRF Scientific retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the XRF Scientific's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the XRF Scientific's total revenue generated. When comparing the revenue margin year over year, investors can gauge the XRF Scientific's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the XRF Scientific. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the XRF Scientific's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
XRF Scientific Margin History
| XRF Scientific Gross margin | XRF Scientific Profit margin | XRF Scientific EBIT margin | XRF Scientific Profit margin |
|---|---|---|---|
| 2026e | 41.59 % | 24.26 % | 15.84 % |
| 2025e | 41.59 % | 24.29 % | 15.8 % |
| 2024e | 41.59 % | 23.35 % | 15.19 % |
| 2023 | 41.59 % | 21.66 % | 13.91 % |
| 2022 | 43.3 % | 20.58 % | 15.21 % |
| 2021 | 44.07 % | 19.05 % | 16.39 % |
| 2020 | 42.12 % | 15.85 % | 10.73 % |
| 2019 | 39.12 % | 11.58 % | 7.36 % |
| 2018 | 39.81 % | 7.49 % | 4.22 % |
| 2017 | 41.23 % | 5.55 % | 3.69 % |
| 2016 | 40.61 % | 11.93 % | 7.27 % |
| 2015 | 42.08 % | 18.81 % | 12.77 % |
| 2014 | 39.41 % | 18.17 % | 11.17 % |
| 2013 | 41.34 % | 23.32 % | 16.7 % |
| 2012 | 38.18 % | 20.1 % | 13.92 % |
| 2011 | 41.07 % | 20.95 % | 12.94 % |
| 2010 | 36.94 % | 5.77 % | 2.4 % |
| 2009 | 39.14 % | 12.61 % | 11.6 % |
| 2008 | 37.25 % | 9.38 % | 6.25 % |
| 2007 | 40.3 % | 6.76 % | 1.91 % |
| 2006 | 48.17 % | 12.79 % | 10.47 % |
| 2005 | 55.78 % | 9.57 % | 5.94 % |
| 2004 | 52.75 % | 10.18 % | 10.35 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 52.75 % | 10.18 % | 10.35 % |
| 2005 | 55.78 % | 9.57 % | 5.94 % |
| 2006 | 48.17 % | 12.79 % | 10.47 % |
| 2007 | 40.3 % | 6.76 % | 1.91 % |
| 2008 | 37.25 % | 9.38 % | 6.25 % |
| 2009 | 39.14 % | 12.61 % | 11.6 % |
| 2010 | 36.94 % | 5.77 % | 2.4 % |
| 2011 | 41.07 % | 20.95 % | 12.94 % |
| 2012 | 38.18 % | 20.1 % | 13.92 % |
| 2013 | 41.34 % | 23.32 % | 16.7 % |
| 2014 | 39.41 % | 18.17 % | 11.17 % |
| 2015 | 42.08 % | 18.81 % | 12.77 % |
| 2016 | 40.61 % | 11.93 % | 7.27 % |
| 2017 | 41.23 % | 5.55 % | 3.69 % |
| 2018 | 39.81 % | 7.49 % | 4.22 % |
| 2019 | 39.12 % | 11.58 % | 7.36 % |
| 2020 | 42.12 % | 15.85 % | 10.73 % |
| 2021 | 44.07 % | 19.05 % | 16.39 % |
| 2022 | 43.3 % | 20.58 % | 15.21 % |
| 2023 | 41.59 % | 21.66 % | 13.91 % |
| 2024e | 41.59 % | 23.35 % | 15.19 % |
| 2025e | 41.59 % | 24.29 % | 15.8 % |
| 2026e | 41.59 % | 24.26 % | 15.84 % |
XRF Scientific Stock Sales Revenue, EBIT, Earnings per Share AU000000XRF8 ·
The XRF Scientific earnings per share therefore indicates how much revenue XRF Scientific has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
3 years
5 years
10 years
Max
Sales per Share
EBIT per share
Earnings per Share
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue XRF Scientific earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates XRF Scientific's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of XRF Scientific’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating XRF Scientific's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
XRF Scientific Revenue, EBIT and net profit per share
| Date | XRF Scientific Sales per Share | XRF Scientific EBIT per share | XRF Scientific Earnings per Share |
|---|---|---|---|
| 2026e | 0.5 AUD | 0 AUD | 0.08 AUD |
| 2025e | 0.47 AUD | 0 AUD | 0.07 AUD |
| 2024e | 0.43 AUD | 0 AUD | 0.07 AUD |
| 2023 | 0.4 AUD | 0.09 AUD | 0.06 AUD |
| 2022 | 0.3 AUD | 0.06 AUD | 0.04 AUD |
| 2021 | 0.23 AUD | 0.04 AUD | 0.04 AUD |
| 2020 | 0.22 AUD | 0.03 AUD | 0.02 AUD |
| 2019 | 0.22 AUD | 0.03 AUD | 0.02 AUD |
| 2018 | 0.18 AUD | 0.01 AUD | 0.01 AUD |
| 2017 | 0.16 AUD | 0.01 AUD | 0.01 AUD |
| 2016 | 0.16 AUD | 0.02 AUD | 0.01 AUD |
| 2015 | 0.16 AUD | 0.03 AUD | 0.02 AUD |
| 2014 | 0.17 AUD | 0.03 AUD | 0.02 AUD |
| 2013 | 0.17 AUD | 0.04 AUD | 0.03 AUD |
| 2012 | 0.2 AUD | 0.04 AUD | 0.03 AUD |
| 2011 | 0.2 AUD | 0.04 AUD | 0.03 AUD |
| 2010 | 0.14 AUD | 0.01 AUD | 0 AUD |
| 2009 | 0.18 AUD | 0.02 AUD | 0.02 AUD |
| 2008 | 0.16 AUD | 0.02 AUD | 0.01 AUD |
| 2007 | 0.15 AUD | 0.01 AUD | 0 AUD |
| 2006 | 0.15 AUD | 0.02 AUD | 0.02 AUD |
| 2005 | 0.05 AUD | 0 AUD | 0 AUD |
| 2004 | 0.1 AUD | 0.01 AUD | 0.01 AUD |
| Sales per Share | EBIT per share | Earnings per Share | |
|---|---|---|---|
| 2004 | 0.1 AUD | 0.01 AUD | 0.01 AUD |
| 2005 | 0.05 AUD | 0 AUD | 0 AUD |
| 2006 | 0.15 AUD | 0.02 AUD | 0.02 AUD |
| 2007 | 0.15 AUD | 0.01 AUD | 0 AUD |
| 2008 | 0.16 AUD | 0.02 AUD | 0.01 AUD |
| 2009 | 0.18 AUD | 0.02 AUD | 0.02 AUD |
| 2010 | 0.14 AUD | 0.01 AUD | 0 AUD |
| 2011 | 0.2 AUD | 0.04 AUD | 0.03 AUD |
| 2012 | 0.2 AUD | 0.04 AUD | 0.03 AUD |
| 2013 | 0.17 AUD | 0.04 AUD | 0.03 AUD |
| 2014 | 0.17 AUD | 0.03 AUD | 0.02 AUD |
| 2015 | 0.16 AUD | 0.03 AUD | 0.02 AUD |
| 2016 | 0.16 AUD | 0.02 AUD | 0.01 AUD |
| 2017 | 0.16 AUD | 0.01 AUD | 0.01 AUD |
| 2018 | 0.18 AUD | 0.01 AUD | 0.01 AUD |
| 2019 | 0.22 AUD | 0.03 AUD | 0.02 AUD |
| 2020 | 0.22 AUD | 0.03 AUD | 0.02 AUD |
| 2021 | 0.23 AUD | 0.04 AUD | 0.04 AUD |
| 2022 | 0.3 AUD | 0.06 AUD | 0.04 AUD |
| 2023 | 0.4 AUD | 0.09 AUD | 0.06 AUD |
| 2024e | 0.43 AUD | 0 AUD | 0.07 AUD |
| 2025e | 0.47 AUD | 0 AUD | 0.07 AUD |
| 2026e | 0.5 AUD | 0 AUD | 0.08 AUD |
XRF Scientific business model
XRF Scientific is one of the most popular companies on Eulerpool.com.
XRF Scientific valuation based on historical P/E ratio, EBIT, and P/S ratio.
XRF Scientific shares outstanding AU000000XRF8 ·
The number of shares was XRF Scientific in 2023 — This indicates how many shares 136.688 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue XRF Scientific earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates XRF Scientific's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of XRF Scientific’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating XRF Scientific's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2004 | 60.79 M Aktien |
| 2005 | 60.79 M Aktien |
| 2006 | 38.89 M Aktien |
| 2007 | 85.69 M Aktien |
| 2008 | 90.33 M Aktien |
| 2009 | 91.61 M Aktien |
| 2010 | 91.61 M Aktien |
| 2011 | 103.63 M Aktien |
| 2012 | 127.13 M Aktien |
| 2013 | 130.73 M Aktien |
| 2014 | 132.16 M Aktien |
| 2015 | 132.16 M Aktien |
| 2016 | 133.13 M Aktien |
| 2017 | 133.83 M Aktien |
| 2018 | 133.83 M Aktien |
| 2019 | 133.83 M Aktien |
| 2020 | 133.83 M Aktien |
| 2021 | 134.35 M Aktien |
| 2022 | 135.47 M Aktien |
| 2023 | 136.69 M Aktien |
| 2024e | 136.69 M Aktien |
| 2025e | 136.69 M Aktien |
| 2026e | 136.69 M Aktien |
XRF Scientific Stock Dividend AU000000XRF8 ·
In 2023, XRF Scientific paid a dividend amounting to 0.05 AUD. Dividend means that XRF Scientific distributes a portion of its profits to its owners.
3 years
5 years
10 years
Max
Dividend
Dividend (Estimate)
Details
Dividend
ⓘDividend Overview
The dividend per year chart for XRF Scientific provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.
Interpretation and Use
A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify XRF Scientific’s potential for long-term investment and income generation through dividends.
Investment Strategy
Incorporate the dividend data in evaluating XRF Scientific's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.
XRF Scientific Dividend History
| Date | XRF Scientific Dividend |
|---|---|
| 2026e | 0.05 AUD |
| 2025e | 0.05 AUD |
| 2024e | 0.05 AUD |
| 2023 | 0.05 AUD |
| 2022 | 0.03 AUD |
| 2021 | 0.03 AUD |
| 2020 | 0.02 AUD |
| 2019 | 0.01 AUD |
| 2018 | 0 AUD |
| 2017 | 0 AUD |
| 2016 | 0.01 AUD |
| 2015 | 0.02 AUD |
| 2014 | 0.02 AUD |
| 2013 | 0.02 AUD |
| 2012 | 0.02 AUD |
| 2011 | 0.01 AUD |
| 2009 | 0.01 AUD |
| 2008 | 0.01 AUD |
| Dividend | Dividend (Estimate) | |
|---|---|---|
| 2004 | 0 AUD | 0 AUD |
| 2005 | 0 AUD | 0 AUD |
| 2006 | 0 AUD | 0 AUD |
| 2007 | 0 AUD | 0 AUD |
| 2008 | 0.01 AUD | 0 AUD |
| 2009 | 0.01 AUD | 0 AUD |
| 2010 | 0 AUD | 0 AUD |
| 2011 | 0.01 AUD | 0 AUD |
| 2012 | 0.02 AUD | 0 AUD |
| 2013 | 0.02 AUD | 0 AUD |
| 2014 | 0.02 AUD | 0 AUD |
| 2015 | 0.02 AUD | 0 AUD |
| 2016 | 0.01 AUD | 0 AUD |
| 2017 | 0 AUD | 0 AUD |
| 2018 | 0 AUD | 0 AUD |
| 2019 | 0.01 AUD | 0 AUD |
| 2020 | 0.02 AUD | 0 AUD |
| 2021 | 0.03 AUD | 0 AUD |
| 2022 | 0.03 AUD | 0 AUD |
| 2023 | 0.05 AUD | 0 AUD |
| 2024e | 0 AUD | 0.05 AUD |
| 2025e | 0 AUD | 0.05 AUD |
| 2026e | 0 AUD | 0.05 AUD |
XRF Scientific Stock Payout Ratio AU000000XRF8 ·
In 2023, XRF Scientific had a payout ratio of 75.93%. The payout ratio indicates the percentage of the company's profits that XRF Scientific distributes as dividends.
3 years
5 years
10 years
Max
Payout ratio
Details
Payout ratio
ⓘWhat is Yearly Payout Ratio?
The yearly payout ratio for XRF Scientific represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.
How to Interpret the Data
A lower payout ratio for XRF Scientific could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.
Using the Data for Investments
Evaluate XRF Scientific's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.
XRF Scientific Payout Ratio History
| Date | XRF Scientific Payout ratio |
|---|---|
| 2026e | 74.72 % |
| 2025e | 74.6 % |
| 2024e | 73.64 % |
| 2023 | 75.93 % |
| 2022 | 74.22 % |
| 2021 | 70.77 % |
| 2020 | 82.81 % |
| 2019 | 86.37 % |
| 2018 | 54.09 % |
| 2017 | 57.82 % |
| 2016 | 61.84 % |
| 2015 | 85.84 % |
| 2014 | 78.57 % |
| 2013 | 80.95 % |
| 2012 | 71.43 % |
| 2011 | 47.62 % |
| 2010 | 75.93 % |
| 2009 | 53.57 % |
| 2008 | 71.43 % |
| 2007 | 75.93 % |
| 2006 | 75.93 % |
| 2005 | 75.93 % |
| 2004 | 75.93 % |
| Payout ratio | |
|---|---|
| 2004 | 75.93 % |
| 2005 | 75.93 % |
| 2006 | 75.93 % |
| 2007 | 75.93 % |
| 2008 | 71.43 % |
| 2009 | 53.57 % |
| 2010 | 75.93 % |
| 2011 | 47.62 % |
| 2012 | 71.43 % |
| 2013 | 80.95 % |
| 2014 | 78.57 % |
| 2015 | 85.84 % |
| 2016 | 61.84 % |
| 2017 | 57.82 % |
| 2018 | 54.09 % |
| 2019 | 86.37 % |
| 2020 | 82.81 % |
| 2021 | 70.77 % |
| 2022 | 74.22 % |
| 2023 | 75.93 % |
| 2024e | 73.64 % |
| 2025e | 74.6 % |
| 2026e | 74.72 % |
Unfortunately, there are currently no price targets and forecasts available for XRF Scientific.
XRF Scientific Earnings Surprises
| Date | EPS Estimate | EPS Actual | Quarterly report |
|---|---|---|---|
| 6/30/2023 | 0.03 AUD | 0.03 AUD (-10.54 %) | 2023 Q4 |
| 6/30/2022 | 0.02 AUD | 0.02 AUD (18.81 %) | 2022 Q4 |
| 6/30/2021 | 0.01 AUD | 0.02 AUD (80.18 %) | 2021 Q4 |
| 12/31/2017 | 0.01 AUD | 0.01 AUD (40.85 %) | 2018 Q2 |
| 6/30/2013 | 0.01 AUD | 0.01 AUD (-14.89 %) | 2013 Q4 |
1
XRF Scientific Stock Shareholders
% | Name | Stocks | Change | Date |
|---|---|---|---|---|
| 7.81 % | Korber (Michael Karl) | 10,789,750 | -359,327 | 7/31/2023 |
| 7.38 % | Brown (David) | 10,192,200 | 20,000 | 9/26/2023 |
| 5.12 % | Evelin Investments Pty. Ltd. | 7,064,539 | 257,830 | 7/31/2023 |
| 2.10 % | Mandel Pty. Ltd. | 2,900,000 | 550,000 | 7/31/2023 |
| 2.06 % | Great Western Capital Pty. Ltd. | 2,838,648 | 103,600 | 7/31/2023 |
| 1.93 % | Prossor (Stephen William) | 2,669,767 | 0 | 7/31/2023 |
| 1.77 % | Pebadore Pty. Ltd. | 2,450,000 | 75,000 | 7/31/2023 |
| 1.60 % | G & E Properties Pty Ltd | 2,206,275 | 0 | 7/31/2023 |
| 1.22 % | Beta Gamma Pty. Ltd. | 1,682,033 | 61,388 | 7/31/2023 |
| 1.21 % | Davidts (Frederic) | 1,671,176 | 1,000 | 7/31/2023 |
1
2
3
XRF Scientific Executives and Management Board
Mr. Vance Stazzonelli
XRF Scientific Managing Director, Executive Director, Joint Company Secretary (since 2008)
Compensation 774,385 AUD
Mr. Andrew Watson
XRF Scientific Chief Financial Officer, Joint Company Secretary
Compensation 403,943 AUD
Mr. David Brown
XRF Scientific Non-Executive Director (since 2004)
Compensation 280,172 AUD
Mr. Frederick Grimwade64
XRF Scientific Non-Executive Chairman of the Board
Compensation 103,400 AUD
Mr. David Kiggins
XRF Scientific Non-Executive Independent Director
Compensation 71,505 AUD
1
XRF Scientific stock: Frequently Asked Questions
What is the P/S ratio of XRF Scientific 2024?
The XRF Scientific P/S ratio is 3.09.
What is the AlleAktien quality score of XRF Scientific?
The AlleAktien quality score for XRF Scientific is 9/10.
What is the revenue of XRF Scientific 2024?
The expected XRF Scientific revenue is 59.69 M AUD.
How high is the profit of XRF Scientific 2024?
The expected XRF Scientific profit is 9.07 M AUD.
What is the business model of XRF Scientific
No history available for XRF Scientific.
What is the XRF Scientific dividend?
XRF Scientific pays a dividend of 0.03 AUD distributed over payouts per year.
How often does XRF Scientific pay dividends?
The dividend cannot currently be calculated for XRF Scientific or the company does not pay out a dividend.
What is the XRF Scientific ISIN?
The ISIN of XRF Scientific is AU000000XRF8.
What is the XRF Scientific ticker?
The ticker of XRF Scientific is XRF.AX.
How much dividend does XRF Scientific pay?
Over the past 12 months, XRF Scientific paid a dividend of 0.05 AUD . This corresponds to a dividend yield of about 3.49 %. For the coming 12 months, XRF Scientific is expected to pay a dividend of 0.05 AUD.
What is the dividend yield of XRF Scientific?
The current dividend yield of XRF Scientific is 3.49 %.
When does XRF Scientific pay dividends?
XRF Scientific pays a quarterly dividend. This is distributed in the months of November, October, October, October.
How secure is the dividend of XRF Scientific?
XRF Scientific paid dividends every year for the past 16 years.
What is the dividend of XRF Scientific?
For the upcoming 12 months, dividends amounting to 0.05 AUD are expected. This corresponds to a dividend yield of 3.44 %.
In which sector is XRF Scientific located?
XRF Scientific is assigned to the 'Industry' sector.
Wann musste ich die Aktien von XRF Scientific kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of XRF Scientific from 10/13/2023 amounting to 0.047 AUD, you needed to have the stock in your portfolio before the ex-date on 9/28/2023.
When did XRF Scientific pay the last dividend?
The last dividend was paid out on 10/13/2023.
What was the dividend of XRF Scientific in the year 2023?
In the year 2023, XRF Scientific distributed 0.033 AUD as dividends.
In which currency does XRF Scientific pay out the dividend?
The dividends of XRF Scientific are distributed in AUD.
XRF Scientific stock price, news, forecast, analysis
Sector
Industry
Industry
Industrial Machinery & Supplies & Components
Number of shares
Employee
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website
Country
Australia 🇦🇺
Currency
AUD
Initial public offering
Oct 31, 2006
GOSIN
Global Open Securities Identification Number
Cusip
Q98664107
Market capitalization
PEG
3.83
P/E
Forward P/E
20.56
P/S
Forward P/S
2.86
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC
5.75 %
Dividend
Dividend yield
3.49 %
Dividend growth Ø5Y
27.86 %
Dividends per year
Paid since
13 years
Not cut since
6 years
Increased since
6 years
Dividends tax
0 %
Scalable Capital savings plan Nein
Trade Republic savings plan Nein
comdirect savings plan
Consorsbank savings plan Nein
ING savings plan Nein
XRF Scientific Peer Group
XRF Scientific Eulerpool News
XRF Scientific News
XRF Scientific Ticker
| Stock Exchange | XRF Scientific Ticker |
|---|---|
| ASX | XRF.AX |
XRF Scientific FIGI
| XRF Scientific Ticker | XRF Scientific FIGI |
|---|---|
| XRF:AU | BBG000G6NJ29 |
| XRF:AT | BBG000G6NJP4 |
| XRF:AH | BBG002F3LFH7 |
| XRFSF:US | BBG00564TQK2 |
| XRFSF:PQ | BBG00564TQZ6 |
| XRFSF:UV | BBG00564TR11 |
| XRFAUD:XH | BBG00ZV6KB07 |
| XRFAUD:XF | BBG00ZV6KB25 |
| XRFAUD:XE | BBG00ZV6KB43 |
| XRFAUD:XL | BBG00ZV6KB61 |
| XRFAUD:XG | BBG00ZV6KB70 |
| XRFAUD:XO | BBG00ZV6KB89 |
| XRFAUD:XA | BBG00ZV6KBD3 |
| XRFAUD:XT | BBG00ZV6KBG0 |
| XRFAUD:XW | BBG00ZV6KBH9 |
| XRFAUD:XU | BBG00ZV6KBJ7 |
| XRFAUD:XV | BBG00ZV6KBL4 |
| XRFAUD:XM | BBG00ZV6KBM3 |
| XRFAUD:EU | BBG00ZV6KBV3 |
Other fundamentals and analyses of XRF Scientific in the deep dive.
Our stock analysis for XRF Scientific Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of XRF Scientific Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- XRF Scientific Revenue
- XRF Scientific Net Income
- XRF Scientific P/E
- XRF Scientific P/S
- XRF Scientific EBIT
- XRF Scientific Dividend
- XRF Scientific Stocks
- XRF Scientific Market capitalization
- XRF Scientific Debt
- XRF Scientific Liabilities
- XRF Scientific Equity
- XRF Scientific AAQS
- XRF Scientific Employees
- XRF Scientific ROE
- XRF Scientific ROA
- XRF Scientific ROCE